ArticleCirculation2017
Unpacking and Understanding the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Apolipoprotein B Metabolism.
Chris J PackardPubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it